Relmada Therapeutics Historical PE Ratio image   This RLMD PE ratio history page last updated 4/15/2024
Relmada Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/19/2024
5.37-0.84-3.36NA
Q3 2023
11/8/2023
3.00-0.73-2.92NA
Q2 2023
8/8/2023
2.54-0.84-3.36NA
Q1 2023
5/11/2023
3.17-0.87-3.48NA
Q4 2022
3/23/2023
2.32-1.28-5.12NA
Q3 2022
11/10/2022
5.84-1.31-5.24NA
Q2 2022
8/11/2022
27.82-1.33-5.32NA
Q1 2022
5/5/2022
22.40-1.40-5.60NA
Q4 2021
3/23/2022
23.33-1.80-7.20NA
Q3 2021
11/11/2021
25.66-2.44-9.76NA
Q2 2021
8/10/2021
23.00-1.56-6.24NA
Q1 2021
5/12/2021
33.61-1.34-5.36NA
Q4 2020
3/23/2021
34.34-1.28-5.12NA
Q3 2020
11/12/2020
32.85-1.05-4.20NA
Q2 2020
8/12/2020
37.26-0.73-2.92NA
Relmada Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/19/2024
5.37-0.84-3.28NA
Q3 2023
11/8/2023
3.00-0.73-3.72NA
Q2 2023
8/8/2023
2.54-0.84-4.30NA
Q1 2023
5/11/2023
3.17-0.87-4.79NA
Q4 2022
3/23/2023
2.32-1.28-5.32NA
Q3 2022
11/10/2022
5.84-1.31-5.84NA
Q2 2022
8/11/2022
27.82-1.33-6.97NA
Q1 2022
5/5/2022
22.40-1.40-7.20NA
Q4 2021
3/23/2022
23.33-1.80-7.14NA
Q3 2021
11/11/2021
25.66-2.44-6.62NA
Q2 2021
8/10/2021
23.00-1.56-5.23NA
Q1 2021
5/12/2021
33.61-1.34-4.40NA
Q4 2020
3/23/2021
34.34-1.28NANA
Q3 2020
11/12/2020
32.85-1.05NANA
Q2 2020
8/12/2020
37.26-0.73NANA
Quotes delayed 20 minutes

Email EnvelopeFree RLMD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Relmada Therapeutics (RLMD) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

RLYB PE Ratio History
RMD PE Ratio History
RMED PE Ratio History
RMTI PE Ratio History
RNA PE Ratio History
RNAC PE Ratio History
RNAZ PE Ratio History
RNXT PE Ratio History
RPHM PE Ratio History
RPID PE Ratio History
How should the RLMD historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Relmada Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this RLMD Historical PE Ratio page.

What is the average historical PE for RLMD based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The RLMD historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for RLMD based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The RLMD historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Relmada Therapeutics Historical PE Ratio information for Relmada Therapeutics' stock. The average RLMD historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average RLMD historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this RLMD historical PE result, against the recent PE: when this page was posted on 4/12/2024, the most recent closing price for RLMD had been 4.65, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on RLMD or any other given stock, valuation analysis for RLMD can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Relmada Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RLMD. Thanks for visiting, and the next time you need to research RLMD Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: FXCB Videos, SUSQ Historical Stock Prices, Funds Holding FTPA.

 

Relmada Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.